Pallas Capital Advisors LLC Purchases Shares of 1,994 Chemed Corporation $CHE

Pallas Capital Advisors LLC purchased a new stake in Chemed Corporation (NYSE:CHE) during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 1,994 shares of the company’s stock, valued at approximately $929,000.

A number of other institutional investors also recently modified their holdings of CHE. Commonwealth Equity Services LLC grew its holdings in shares of Chemed by 3.1% during the fourth quarter. Commonwealth Equity Services LLC now owns 734 shares of the company’s stock worth $314,000 after buying an additional 22 shares in the last quarter. Cim LLC lifted its stake in Chemed by 1.1% in the 3rd quarter. Cim LLC now owns 2,139 shares of the company’s stock valued at $958,000 after acquiring an additional 24 shares in the last quarter. Eukles Asset Management boosted its position in Chemed by 0.4% during the 4th quarter. Eukles Asset Management now owns 6,056 shares of the company’s stock worth $2,591,000 after acquiring an additional 25 shares during the last quarter. MassMutual Private Wealth & Trust FSB boosted its position in Chemed by 65.3% during the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 81 shares of the company’s stock worth $38,000 after acquiring an additional 32 shares during the last quarter. Finally, EverSource Wealth Advisors LLC grew its stake in shares of Chemed by 9.4% during the 1st quarter. EverSource Wealth Advisors LLC now owns 406 shares of the company’s stock worth $153,000 after acquiring an additional 35 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on CHE shares. Oppenheimer lifted their price objective on shares of Chemed from $500.00 to $590.00 and gave the company an “outperform” rating in a report on Friday, July 31st. Wall Street Zen upgraded shares of Chemed from a “hold” rating to a “strong-buy” rating in a report on Saturday, August 1st. Royal Bank Of Canada raised their target price on shares of Chemed from $436.00 to $548.00 and gave the company a “sector perform” rating in a research report on Thursday, July 30th. Bank of America reiterated a “neutral” rating on shares of Chemed in a research note on Wednesday, July 29th. Finally, Weiss Ratings raised shares of Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, July 17th. One research analyst has rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $530.75.

Chemed Stock Up 0.9%

CHE stock opened at $529.93 on Wednesday. The company has a market cap of $6.93 billion, a price-to-earnings ratio of 26.62, a P/E/G ratio of 2.02 and a beta of 0.51. Chemed Corporation has a twelve month low of $365.20 and a twelve month high of $557.00. The business has a 50 day moving average price of $492.50 and a two-hundred day moving average price of $444.25. The company has a quick ratio of 0.89, a current ratio of 0.91 and a debt-to-equity ratio of 0.17.

Chemed (NYSE:CHE) last announced its quarterly earnings data on Tuesday, July 28th. The company reported $6.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.60 by $0.46. The company had revenue of $673.25 million for the quarter, compared to analysts’ expectations of $665.04 million. Chemed had a return on equity of 31.77% and a net margin of 10.60%.The business’s revenue was up 8.8% compared to the same quarter last year. During the same quarter in the prior year, the business posted $4.27 EPS. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. Analysts anticipate that Chemed Corporation will post 23.18 EPS for the current fiscal year.

Chemed Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, September 3rd. Shareholders of record on Monday, August 17th will be given a dividend of $0.70 per share. This represents a $2.80 annualized dividend and a yield of 0.5%. This is an increase from Chemed’s previous quarterly dividend of $0.60. The ex-dividend date of this dividend is Monday, August 17th. Chemed’s payout ratio is currently 12.05%.

Insider Buying and Selling at Chemed

In other Chemed news, Director Patrick P. Grace sold 190 shares of the stock in a transaction on Friday, July 31st. The shares were sold at an average price of $532.00, for a total value of $101,080.00. Following the completion of the sale, the director owned 3,533 shares in the company, valued at $1,879,556. This trade represents a 5.10% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Andrea R. Lindell sold 1,347 shares of Chemed stock in a transaction dated Tuesday, June 9th. The shares were sold at an average price of $447.33, for a total transaction of $602,553.51. Following the completion of the transaction, the director directly owned 4,578 shares of the company’s stock, valued at approximately $2,047,876.74. This trade represents a 22.73% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 3,537 shares of company stock worth $1,782,654 over the last quarter. 3.33% of the stock is currently owned by insiders.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.